FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in glioma. We previously identified a spliced isoform (FKBP51s) and highlighted a role for this protein in the upregulation of Programmed Death Ligand 1 (PD-L1) expression in melanoma. Because gliomas can express PD-L1 causing a defective host anti-tumoral immunity, we investigated whether FKBP51s was expressed in glioma and played a role in PD-L1 regulation in this tumour
Despite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1), treatment w...
The development of immune checkpoint blockade therapy has ushered in a new era of cancer treatment. ...
peer reviewedDespite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1)...
FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in glioma. We previously iden...
peer reviewedBACKGROUND: FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in g...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
Among the high-grade malignant gliomas (III-IV), grade IV glioma, or glioblastoma (GBM), is the most...
Glioblastoma Multiforme is one of the most aggressive form of malignancy of the central nervous syst...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
Glioblastoma can avoid immune surveillance and induce tumor tolerance, through inhibitory molecules,...
peer reviewedFKBP51 (gene FKBP5) is an immunophilin capable of immunosuppression expressed in melano...
FKBP51 (gene FKBP5) is an immunophilin capable of immunosuppression expressed in melanoma and lympho...
Abstract Melanoma delivers immune suppressive stimuli through PDL-1. FK506 binding protein 51 (FKBP...
Presentation on the FK506 binding protein (FKBP) 51 as central molecular player in melanoma progress...
Background A cross-talk between certain oncogenic signaling pathways and PD-L1 expression is emergin...
Despite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1), treatment w...
The development of immune checkpoint blockade therapy has ushered in a new era of cancer treatment. ...
peer reviewedDespite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1)...
FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in glioma. We previously iden...
peer reviewedBACKGROUND: FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in g...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
Among the high-grade malignant gliomas (III-IV), grade IV glioma, or glioblastoma (GBM), is the most...
Glioblastoma Multiforme is one of the most aggressive form of malignancy of the central nervous syst...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
Glioblastoma can avoid immune surveillance and induce tumor tolerance, through inhibitory molecules,...
peer reviewedFKBP51 (gene FKBP5) is an immunophilin capable of immunosuppression expressed in melano...
FKBP51 (gene FKBP5) is an immunophilin capable of immunosuppression expressed in melanoma and lympho...
Abstract Melanoma delivers immune suppressive stimuli through PDL-1. FK506 binding protein 51 (FKBP...
Presentation on the FK506 binding protein (FKBP) 51 as central molecular player in melanoma progress...
Background A cross-talk between certain oncogenic signaling pathways and PD-L1 expression is emergin...
Despite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1), treatment w...
The development of immune checkpoint blockade therapy has ushered in a new era of cancer treatment. ...
peer reviewedDespite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1)...